Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Radiology.
Invest Radiol. 2020 May;55(5):285-292. doi: 10.1097/RLI.0000000000000639.
Magnetic resonance imaging (MRI) of the abdomen increasingly incorporates diffusion-weighted imaging (DWI) sequences. Whereas DWI can substantially aid in detecting and characterizing suspicious findings, it remains unclear to what extent the use of ultra-high b-value DWI might further be of aid for the radiologist especially when using DWI sequences with advanced processing. The target of this study was therefore to compare high and ultra-high b-value DWI in abdominal MRI examinations.
This institutional review board-approved, prospective study included abdominal MRI examinations of 70 oncologic patients (mean age, 58 years; range, 21-90 years) examined with a clinical 1.5 T MRI scanner (MAGNETOM Aera, Siemens Healthcare, Erlangen, Germany) with an advanced echo planar DWI sequence (b = 0, 50, 900, and 1500 s/mm) after ex vivo phantom and in vivo volunteer investigations. High b900 and ultra-high b1500 DWIs were compared by a qualitative reading for image quality and lesion conspicuity using a 5-point Likert scale with 2 radiologists as readers. The ratios of apparent signal intensities of suspicious lesions/normal tissue of the same organ (LNTRs) were calculated. Appropriate methods were used for statistical analysis, including Wilcoxon signed-rank test and κ statistic for interreader agreement analysis (P < 0.05/0.0125/0.005 after Bonferroni correction).
Image quality was significantly increased with b900 as compared with b1500 DWI (P < 0.001) despite using an advanced DWI sequence. A total of 153 suspicious lesions were analyzed. Overall reader confidence for characterization/detection of malignant lesions and, correspondingly, the LNTR (mean, 2.7 ± 1.8 vs 2.4 ± 1.6) were significantly higher with b900 than with b1500 DWI (P < 0.001 and P < 0.001). The increased confidence of lesion recognition and LNTR in the b900 DWI remained significant qualitatively in lymphatic and hepatic lesions and quantitatively in lymphatic, pulmonal, and osseous lesions.
Using high b-value DWI (900 s/mm) provided an improved image quality and also lesion conspicuity as compared with ultra-high b-value DWI (1500 s/mm) in oncologic abdominal examinations despite using advanced processing. Consequently, the value for additional ultra-high b-value DWI in oncologic examinations should be critically evaluated in future studies.
腹部磁共振成像(MRI)越来越多地采用弥散加权成像(DWI)序列。虽然 DWI 可以极大地帮助检测和描述可疑发现,但对于放射科医生来说,使用超高 b 值 DWI 可以在多大程度上进一步提供帮助,特别是在使用具有先进处理功能的 DWI 序列时,这一点仍不清楚。因此,本研究的目的是比较腹部 MRI 检查中的高 b 值和超高 b 值 DWI。
本研究经机构审查委员会批准,前瞻性纳入 70 例肿瘤患者(平均年龄 58 岁;范围 21-90 岁)的腹部 MRI 检查,这些患者使用临床 1.5 T MRI 扫描仪(德国西门子医疗公司的 MAGNETOM Aera)进行检查,该扫描仪配备了先进的回波平面 DWI 序列(b=0、50、900 和 1500 s/mm),在离体体模和体内志愿者研究后进行。两名放射科医生作为读者,使用 5 分李克特量表对高 b900 和超高 b1500 DWI 的图像质量和病变显著性进行定性评估。计算可疑病变/同一器官正常组织的表观信号强度比(LNTRs)。使用适当的方法进行统计学分析,包括 Wilcoxon 符号秩检验和κ统计量进行读者间一致性分析(P<0.05/0.0125/0.005,经 Bonferroni 校正后)。
尽管使用了先进的 DWI 序列,但与 b1500 DWI 相比,b900 DWI 可显著提高图像质量(P<0.001)。共分析了 153 个可疑病变。总体而言,读者对恶性病变的特征描述/检测的信心以及相应的 LNTR(平均值,2.7±1.8 比 2.4±1.6),b900 明显高于 b1500(P<0.001 和 P<0.001)。b900 DWI 中病变识别和 LNTR 的增加,在淋巴结和肝脏病变的定性分析中以及在淋巴结、肺和骨病变的定量分析中仍然具有统计学意义。
尽管使用了先进的处理功能,但在肿瘤腹部检查中,与超高 b 值 DWI(1500 s/mm)相比,高 b 值 DWI(900 s/mm)可提供更高的图像质量和病变显著性。因此,在未来的研究中,应批判性地评估在肿瘤检查中额外使用超高 b 值 DWI 的价值。